Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019

SELL
$12.26 - $18.07 $3.23 Million - $4.76 Million
-263,181 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$13.7 - $28.34 $3.61 Million - $7.46 Million
263,181 New
263,181 $3.85 Million
Q1 2019

May 15, 2019

SELL
$14.45 - $23.7 $3.03 Million - $4.97 Million
-209,759 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$13.52 - $18.8 $2.84 Million - $3.94 Million
209,759 New
209,759 $3.2 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Arrow Mark Colorado Holdings LLC Portfolio

Follow Arrow Mark Colorado Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.